×
| Stock | Total Income | Net Profit | Net Sales | EPS | Market Cap (in Cr) | P/E |
|---|---|---|---|---|---|---|
| Shyama Computronics and Servic | 0.70 | 0.19 | 0.61 | NA | 4.02 | 30.9 |
| Triochem Products Ltd., | 4.59 | 0.88 | NA | 3.60 | 0 | |
| FORTIS HEALTHCARE LTD. | 19491.5 | 2543 | 19282.6 | 3.28 | 46,758 | 59.5 |
| GLAXOSMITHKLINE PHARMACEUTICAL | 9814.2 | 2285.8 | 9463.6 | 13.49 | 42499 | 49.8 |
| BIOCON LTD. | 38562 | 811 | 38214 | 0.21 | 38719 | 47.0 |
Fortis Healthcare Ltd, with Security Code 532843, is a leading player in the Hospital industry, categorized under the Healthcare sector, offering Equity instruments.
| Metrics | Jun 2022 | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 247.1 | 266.0 | 262.2 | 277.4 | 289.0 | 294.1 | 290.7 | 307.4 | 333.4 | 357.1 |
| Expenses | 215.2 | 228.4 | 226.2 | 249.9 | 253.9 | 254.5 | 242.0 | 238.2 | 275.5 | 297.3 |
| Operating Profit | 31.9 | 37.6 | 36.1 | 27.5 | 35.2 | 39.6 | 48.7 | 69.3 | 57.9 | 59.9 |
| OPM % | 12.92% | 14.14% | 13.75% | 9.93% | 12.16% | 13.47% | 16.76% | 22.54% | 17.38% | 16.76% |
| Other Income | 19.4 | 106.1 | 42.3 | 30.1 | 30.6 | 109.8 | 31.7 | 64.6 | 35.4 | 35.9 |
| Interest | 27.9 | 28.1 | 25.5 | 24.8 | 23.3 | 20.8 | 19.4 | 18.4 | 16.8 | 16.3 |
| Depreciation | 28.4 | 28.7 | 29.3 | 29.4 | 24.8 | 25.1 | 25.3 | 25.9 | 26.0 | 27.4 |
| Profit before tax | 7.3 | 35.7 | 14.2 | 3.5 | 17.7 | 42.0 | 35.8 | 57.5 | 50.5 | 120.3 |
| Tax % | -50.8% | 5.1% | 17.8% | 40.5% | 27.1% | 7.9% | 35.9% | 23.7% | 46.9% | 23.8% |
| Net Profit | -7.6 | 82.4 | 19.4 | 2.1 | 12.9 | 95.3 | 22.9 | 68.3 | 26.8 | 39.6 |
| EPS in Rs | -0.1 | 1.09 | 0.26 | 0.03 | 0.17 | 1.26 | 0.3 | 0.9 | 0.36 | 0.52 |
| Metrics | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 1,607.2 | 1,559.9 | 1,642.7 | 1,657.4 | 1,770.0 | 1,679.7 | 1,785.9 | 1,858.9 | 1,988.4 | 1,928.3 |
| Expenses | 1,304.3 | 1,283.4 | 1,371.8 | 1,385.6 | 1,439.8 | 1,395.7 | 1,404.8 | 1,516.4 | 1,553.6 | 1,553.1 |
| Operating Profit | 302.9 | 276.4 | 270.9 | 271.8 | 330.2 | 284.0 | 381.0 | 342.5 | 434.8 | 375.1 |
| OPM % | 18.8% | 17.7% | 16.5% | 16.4% | 18.7% | 16.9% | 21.3% | 18.4% | 21.9% | 19.5% |
| Other Income | 67.1 | 23.2 | 24.3 | 9.6 | 17.2 | 14.5 | 12.9 | 13.2 | -46.5 | 44.7 |
| Interest | 32.8 | 33.4 | 31.7 | 31.5 | 31.8 | 33.0 | 34.7 | 35.3 | 36.4 | 45.2 |
| Depreciation | 76.9 | 82.8 | 81.8 | 79.2 | 84.1 | 86.9 | 92.2 | 91.0 | 95.1 | 97.3 |
| Profit before tax | 208.7 | 172.0 | 171.2 | 169.3 | 227.7 | 170.9 | 263.9 | 229.3 | 316.6 | 253.5 |
| Tax % | 19.1% | 24% | 24.8% | 27.3% | 21.1% | 27.4% | 25.6% | 24.4% | 26.5% | 9% |
| Net Profit | 218.2 | 142.1 | 138.3 | 124.0 | 183.9 | 134.2 | 203.1 | 174.0 | 193.1 | 254.3 |
| EPS in Rs | 2 | 1 | 1 | 1 | 2 | 1 | 2 | 2 | 2 | 3 |
| Compounded Sales Growth | |
|---|---|
| 10 Years: | 12% |
| 5 Years: | 12% |
| 3 Years: | 23% |
| TTM: | 19% |
| Compounded Profit Growth | |
|---|---|
| 10 Years: | 24% |
| 5 Years: | 0% |
| 3 Years: | 80% |
| TTM: | 163% |
| Stock Price CAGR | |
|---|---|
| 10 Years: | 15% |
| 5 Years: | 32% |
| 3 Years: | 35% |
| 1 Year: | 39% |
| Compounded Sales Growth | |
|---|---|
| 10 Years: | 7% |
| 5 Years: | 9% |
| 3 Years: | 20% |
| TTM: | 12% |
| Compounded Profit Growth | |
|---|---|
| 10 Years: | 17% |
| 5 Years: | 43% |
| 3 Years: | 136% |
| TTM: | 47% |
| Stock Price CAGR | |
|---|---|
| 10 Years: | 15% |
| 5 Years: | 32% |
| 3 Years: | 35% |
| 1 Year: | 39% |
Recent Bets
|
Date
|
Stock
|
Party
|
Deal
|
Trans.
|
Quan.
|
Price
|
Value
|
|---|